Byon Co Ltd
032980
Company Profile
Business description
Byon Co Ltd is a South Korea based company engages in the development of cell therapy using stem cell technology and commercialization of myocardial cells. It also manufactures and supplies health food raw materials and processed products, cosmetics, cosmetic containers, and cosmetic auxiliary materials.
Contact
KJ Tower, Bongeunsa-ro 207
13th Floor
Gangnam-gu
Seoul
KORT: +82 25160720
Sector
Industrials
Stock type
Sensitive
Industry
Conglomerates
Fiscal Year End
31 December 2025
Employees
8
Stocks News & Analysis
stocks
Is this still an ASX share to own forever?
Find out how this defensive player has fared after earnings.
stocks
After earnings, is Nvidia stock a buy, a sell, or fairly valued?
No signs of a slowdown in demand for Nvidia’s chips, and the long-term picture looks bright.
stocks
Short-term pain for long-term gain for undervalued ASX share
Cost reductions lower our profit estimates but should lead to improved long-term outcomes.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,074.70 | 34.50 | 0.38% |
| CAC 40 | 7,719.71 | 65.46 | 0.86% |
| DAX 40 | 23,594.80 | 107.47 | 0.46% |
| Dow JONES (US) | 45,271.23 | 24.58 | -0.05% |
| FTSE 100 | 9,177.99 | 61.30 | 0.67% |
| HKSE | 25,343.43 | 153.12 | -0.60% |
| NASDAQ | 21,497.73 | 218.10 | 1.02% |
| Nikkei 225 | 42,458.37 | 519.48 | 1.24% |
| NZX 50 Index | 13,111.70 | 36.89 | 0.28% |
| S&P 500 | 6,448.26 | 32.72 | 0.51% |
| S&P/ASX 200 | 8,803.40 | 36.10 | 0.41% |
| SSE Composite Index | 3,813.56 | 44.58 | -1.16% |